Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Minerva Neurosciences, Inc. (NERV)
USD4.32
+0.30 (+7.46%)
US NASDAQ Healthcare Biotechnology
Address
1601 Trapelo Road 2451
Burlington, MA, US
Burlington, MA, US
CEO
Remy Luthringer
Website
minervaneurosciences.com
IPO
2014-07-01
CIK 1598646 ISIN US6033802058
Description
Minerva Neurosciences, Inc. functions as a biopharmaceutical firm in the clinical development stage, primarily dedicated to uncovering and bringing to market novel therapeutic options for disorders affecting the central nervous system. Its portfolio of experimental treatments notably features roluperidone, an investigational drug aimed at managing schizophrenia, alongside MIN-301, a soluble recombinant variant of the neuregulin-1b1 protein, which is being explored for its potential in treating Parkinson's disease and various other neurodegenerative conditions. The company has a contractual licensing agreement with Mitsubishi Tanabe Pharma Corporation, authorizing the worldwide development, distribution, and import of roluperidone, with the explicit exclusion of the Asian continent. Established in 2007, this organization initially operated as Cyrenaic Pharmaceuticals, Inc. before undergoing a name change to Minerva Neurosciences, Inc. in 2013. Its corporate headquarters are located in Waltham, Massachusetts.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD4.32
+0.30 (+7.46%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
227.1K
Beta
-0.17
Float Shares
5.31M
Free Float %
75.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.80% | -6.65% | -24.11% | -25.61% | +17.46% | +22.14% | +214.74% | -17.76% | -79.34% | -95.01% | -89.86% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (7 ratings, all time)
Buy
Price Targets & DCF
Current price
4.32
Low
5.00
+15.7%
Consensus
5.00
+15.7%
Median
5.00
+15.7%
High
5.00
+15.7%
DCF (Unlevered)
1.98
-54.2%
DCF (Levered)
2.05
-52.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
33% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 1 |
5.00
+15.7%
|
| All Time | 3 |
5.67
+31.3%
|
Quality scores
Altman Z-Score
-21.86
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%-18,347.4% Q1'26: -472.0% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%— Q1'26: +25.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+11.8% Q1'26: +480.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.22× Q1'26: -0.97× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 1 EPS Ana. |
Dec 2027 3 Rev. Ana. 1 EPS Ana. |
Dec 2028 3 Rev. Ana. 1 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
41.18M
est: 41.19M (0.0%)
|
—
est: 333.3K (-100.0%)
|
—
est: 20.00M (-100.0%)
|
—
est: 45.19M (-100.0%)
|
19.76M
19.76M – 19.76M
-56.3% YoY
|
56.49M
56.49M – 56.49M
+185.9% YoY
|
12.75M
12.75M – 12.75M
-77.4% YoY
|
80.86M
80.86M – 80.86M
+534.2% YoY
|
221.38M
221.38M – 221.38M
+173.8% YoY
|
| EBITDA |
2.12M
est: 33.38M (-93.7%)
|
-45.28M
est: 270.1K (-16,864.7%)
|
6.02M
|
-293.42M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
1.94M
est: 33.34M (-94.2%)
|
-45.38M
est: 269.8K (-16,920.1%)
|
6.00M
|
-293.42M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
1.94M
est: 1.81M (+7.1%)
|
-49.91M
est: -51.60M (+3.3%)
|
1.44M
est: -2.54M (+156.7%)
|
-293.42M
est: -13.47M (-2,078.0%)
|
-29.92M
-29.92M – -29.92M
-122.1% YoY
|
-5.83M
-5.83M – -5.83M
+80.5% YoY
|
-5.22M
-5.22M – -5.22M
+10.5% YoY
|
888.7K
888.7K – 888.7K
+117.0% YoY
|
7.53M
7.53M – 7.53M
+747.6% YoY
|
| SGA |
17.29M
est: 36.41M (-52.5%)
|
13.33M
est: 294.7K (+4,422.8%)
|
9.95M
|
9.34M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
0.38
est: 0.24 (+58.7%)
|
-9.35
est: -6.81 (-37.2%)
|
0.19
est: -0.30 (+163.3%)
|
-34.67
est: -1.59 (-2,078.2%)
|
-3.54
-3.54 – -3.54
-122.1% YoY
|
-0.69
-0.69 – -0.69
+80.5% YoY
|
-0.62
-0.62 – -0.62
+10.5% YoY
|
0.11
0.11 – 0.11
+117.0% YoY
|
0.89
0.89 – 0.89
+747.6% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-5.44B
OE per share TTM
-124.68
Owner's Yield
-2,522.17%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
1.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
44
Total invested
230.78M
Insider transactions (90d)
1
Beneficial owners (>5%)
29
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Federated Hermes, Inc. | 9.61M | 22.50% | 9.61M | — | 9.61M | — | HC | Citizenship or place of Organization | 2022-02-14 | ↗ |
| 2 | J. Christopher Donahue | 9.61M | 22.50% | — | 9.61M | — | 9.61M | IN | Citizenship or place of Organization | 2022-02-14 | ↗ |
| 3 | Rhodora J. Donahue | 9.61M | 22.50% | — | 9.61M | — | 9.61M | IN | Citizenship or place of Organization | 2022-02-14 | ↗ |
| 4 | Thomas R. Donahue | 9.61M | 22.50% | — | 9.61M | — | 9.61M | IN | Citizenship or place of Organization | 2022-02-14 | ↗ |
| 5 | Voting Shares Irrevocable Trust | 9.61M | 22.50% | 9.61M | — | 9.61M | — | OO | Citizenship or place of Organization | 2022-02-14 | ↗ |
| 6 | Federated Investors, Inc. | 9.61M | 24.61% | 9.61M | — | 9.61M | — | HC | Citizenship or place of Organization | 2019-12-10 | ↗ |
| 7 | The Vanguard Group - 23-1945930 | 4.03M | 9.42% | — | — | 4.01M | 16.0K | IA | Pennsylvania For | 2022-02-10 | ↗ |
| 8 | Dr. Remy Luthringer | 2.40M | 5.90% | 2.40M | — | 2.40M | — | IN | France | 2019-02-14 | ↗ |
| 9 | Page 5 of 15 | 2.05M | 5.30% | — | 2.05M | — | 2.05M | IA, PN | Delaware | 2018-02-14 | ↗ |
| 10 | Page 6 of 15 | 2.05M | 5.30% | — | 2.05M | — | 2.05M | HC, CO | Delaware | 2018-02-14 | ↗ |
| 11 | Boehringer AG | 1.50M | 20.79% | — | 1.50M | — | 1.50M | CO | — | 2023-07-07 | ↗ |
| 12 | Boehringer Ingelheim International GmbH | 1.50M | 20.79% | — | 1.50M | — | 1.50M | CO | — | 2023-07-07 | ↗ |
| 13 | Assenagon S.A., Assenagon Asset Management S.A. | 1.39M | 3.24% | 1.39M | — | 1.39M | — | FI | Luxembourg | 2021-11-24 | ↗ |
| 14 | Page 2 of 15 | 941.6K | 2.40% | 941.6K | — | 941.6K | — | IV, OO | Delaware | 2018-02-14 | ↗ |
| 15 | Page 4 of 15 | 740.4K | 1.90% | 740.4K | — | 740.4K | — | IV, OO | Delaware | 2018-02-14 | ↗ |
| 16 | Bihua Chen | 607.9K | 1.60% | — | 607.9K | — | — | IN | United States | 2018-02-14 | ↗ |
| 17 | Cormorant Asset Management, LLC | 607.9K | 1.60% | — | 607.9K | — | — | OO | Delaware | 2018-02-14 | ↗ |
| 18 | Cormorant Global Healthcare GP, LLC | 512.2K | 1.30% | — | 512.2K | — | — | OO | Delaware | 2018-02-14 | ↗ |
| 19 | Cormorant Global Healthcare Master Fund, LP | 512.2K | 1.30% | — | 512.2K | — | — | PN | Cayman Islands | 2018-02-14 | ↗ |
| 20 | Abigail P. Johnson | 491.7K | 7.03% | — | — | 491.7K | — | IN | Delaware | 2024-02-09 | ↗ |
| 21 | FMR LLC | 491.7K | 7.03% | 491.7K | — | 491.7K | — | HC | Delaware | 2024-02-09 | ↗ |
| 22 | Point72 Asset Management, L.P. | 470.0K | 4.00% | — | 470.0K | — | 470.0K | PN | Delaware | 2022-08-23 | ↗ |
| 23 | Point72 Capital Advisors, Inc. | 470.0K | 4.00% | — | 470.0K | — | 470.0K | CO | Delaware | 2022-08-23 | ↗ |
| 24 | Steven A. Cohen | 470.0K | 4.00% | — | 470.0K | — | 470.0K | IN | Delaware | 2022-08-23 | ↗ |
| 25 | (1) BlackRock, Inc. | 406.5K | 1.00% | 406.4K | — | 406.5K | — | HC | Delaware | 2021-07-12 | ↗ |
| 26 | Page 3 of 15 | 363.9K | 0.90% | 363.9K | — | 363.9K | — | IV, OO | Delaware | 2018-02-14 | ↗ |
| 27 | Page 7 of 15 | 53.8K | 0.10% | — | 53.8K | — | 53.8K | IA, PN | Delaware | 2018-02-14 | ↗ |
| 28 | Page 8 of 15 | 53.8K | 0.10% | — | 53.8K | — | 53.8K | HC, OO | Delaware | 2018-02-14 | ↗ |
| 29 | Page 9 of 15 | 53.8K | 0.10% | — | 53.8K | — | 53.8K | HC, CO | Delaware | 2018-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
44
+14 vs prev Q
New positions
18
Closed positions
4
Increased
26
Reduced
8
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 1.66M +1.7M (+100.0%) | 6.66B +6.7B (+100.0%) | 21.87% +21.872 pp | 2.20% +2.199 pp | USD4.02 +0.0% | 1 qtrs NEW |
| 2 | FEDERATED HERMES, INC. | 5.37M +4.0M (+297.5%) | 19.46M +16.6M (+579.2%) | 70.97% +53.118 pp | 0.03% +0.027 pp | USD4.00 +0.5% | 15 qtrs — |
| 3 | VIVO CAPITAL, LLC | 4.32M +4.3M (+100.0%) | 17.38M +17.4M (+100.0%) | 57.11% +57.111 pp | 1.12% +1.123 pp | USD4.02 +0.0% | 1 qtrs NEW |
| 4 | JANUS HENDERSON GROUP PLC | 9.0K +9.0K (+100.0%) | 17.15M +17.1M (+100.0%) | 0.12% +0.119 pp | 0.01% +0.008 pp | USD4.02 +0.0% | 1 qtrs NEW |
| 5 | LOGOS GLOBAL MANAGEMENT LP | 3.31M +3.3M (+100.0%) | 13.31M +13.3M (+100.0%) | 43.74% +43.744 pp | 0.80% +0.804 pp | USD4.02 +0.0% | 1 qtrs NEW |
| 6 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.84M +2.8M (+100.0%) | 11.41M +11.4M (+100.0%) | 37.50% +37.495 pp | 0.02% +0.017 pp | USD4.02 +0.0% | 1 qtrs NEW |
| 7 | FARALLON CAPITAL MANAGEMENT LLC | 2.37M +2.4M (+100.0%) | 9.51M +9.5M (+100.0%) | 31.25% +31.246 pp | 0.04% +0.045 pp | USD4.02 +0.0% | 1 qtrs NEW |
| 8 | ALLY BRIDGE GROUP (NY) LLC | 1.66M +1.7M (+100.0%) | 6.66M +6.7M (+100.0%) | 21.87% +21.872 pp | 6.93% +6.933 pp | USD4.02 +0.0% | 1 qtrs NEW |
| 9 | ACUTA CAPITAL PARTNERS, LLC | 709.5K +709.5K (+100.0%) | 2.85M +2.9M (+100.0%) | 9.37% +9.374 pp | 1.94% +1.937 pp | USD4.02 +0.0% | 1 qtrs NEW |
| 10 | VANGUARD GROUP INC | 252.0K +— (+0.0%) | 1.01M +478.9K (+89.6%) | 3.33% +0.000 pp | 0.00% +0.000 pp | USD3.22 +24.8% | 15 qtrs — |
| 11 | RENAISSANCE TECHNOLOGIES LLC | 149.2K +32.7K (+28.1%) | 599.8K +354.6K (+144.6%) | 1.97% +0.432 pp | 0.00% +0.001 pp | USD4.68 -14.1% | 15 qtrs — |
| 12 | MILLENNIUM MANAGEMENT LLC | 137.9K +137.9K (+100.0%) | 554.4K +554.4K (+100.0%) | 1.82% +1.822 pp | 0.00% +0.000 pp | USD4.02 +0.0% | 1 qtrs NEW |
| 13 | BLACKROCK, INC. | 72.7K +— (+0.0%) | 292.1K +139.2K (+91.0%) | 0.96% +0.000 pp | 0.00% +0.000 pp | USD2.67 +50.6% | 6 qtrs — |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 69.9K -5.7K (-7.5%) | 281.1K +120.8K (+75.3%) | 0.92% -0.075 pp | 0.00% +0.000 pp | USD3.67 +9.5% | 15 qtrs — |
| 15 | APELLA CAPITAL, LLC | 42.4K +3.1K (+7.8%) | 170.4K +70.9K (+71.3%) | 0.56% +0.041 pp | 0.00% +0.001 pp | USD2.05 +96.1% | 4 qtrs — |
| 16 | LION POINT CAPITAL, LP | 35.0K +35.0K (+100.0%) | 140.7K +140.7K (+100.0%) | 0.46% +0.462 pp | 0.73% +0.728 pp | USD4.02 +0.0% | 1 qtrs NEW |
| 17 | STATE STREET CORP | 24.0K +7.5K (+45.4%) | 96.6K +61.5K (+175.7%) | 0.32% +0.099 pp | 0.00% +0.000 pp | USD3.95 +1.8% | 15 qtrs — |
| 18 | TWO SIGMA INVESTMENTS, LP | 22.3K +22.3K (+100.0%) | 89.6K +89.6K (+100.0%) | 0.29% +0.295 pp | 0.00% +0.000 pp | USD4.02 +0.0% | 1 qtrs NEW |
| 19 | MORGAN STANLEY | 11.1K +47.0 (+0.4%) | 44.4K +21.3K (+91.8%) | 0.15% +0.001 pp | 0.00% +0.000 pp | USD3.98 +1.0% | 15 qtrs — |
| 20 | ACADIAN ASSET MANAGEMENT LLC | 10.6K -6.8K (-39.3%) | 42.0K +6.0K (+16.7%) | 0.14% -0.090 pp | 0.00% +0.000 pp | USD3.31 +21.5% | 15 qtrs — |
| 21 | ROYAL BANK OF CANADA | 2.2K -190.0 (-7.8%) | 9.0K +4.0K (+80.0%) | 0.03% -0.003 pp | 0.00% +0.000 pp | USD2.11 +90.5% | 2 qtrs — |
| 22 | UBS GROUP AG | 1.8K +1.8K (+17,970.0%) | 7.3K +7.2K (+34,490.5%) | 0.02% +0.024 pp | 0.00% +0.000 pp | USD4.01 +0.2% | 11 qtrs — |
| 23 | DEUTSCHE BANK AG\ | 1.5K +1.5K (+100.0%) | 6.0K +6.0K (+100.0%) | 0.02% +0.020 pp | 0.00% +0.000 pp | USD4.02 +0.0% | 1 qtrs NEW |
| 24 | TOWER RESEARCH CAPITAL LLC (TRC) | 501.00 -840.0 (-62.6%) | 2.0K -809.0 (-28.7%) | 0.01% -0.011 pp | 0.00% +0.000 pp | USD2.72 +47.8% | 12 qtrs — |
| 25 | CWM, LLC | 420.00 +— (+0.0%) | 2.0K +1.0K (+100.0%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD2.11 +90.5% | 2 qtrs — |
| 26 | LARSON FINANCIAL GROUP LLC | 400.00 +400.0 (+100.0%) | 1.6K +1.6K (+100.0%) | 0.01% +0.005 pp | 0.00% +0.000 pp | USD4.02 +0.0% | 1 qtrs NEW |
| 27 | SBI SECURITIES CO., LTD. | 251.00 +89.0 (+54.9%) | 1.0K +668.0 (+195.9%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD2.63 +52.9% | 5 qtrs — |
| 28 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 100.00 +— (+0.0%) | 402.00 +191.0 (+90.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD9.23 -56.4% | 14 qtrs — |
| 29 | BNP PARIBAS ARBITRAGE, SNC | 62.00 +— (+0.0%) | 249.00 +118.0 (+90.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.21 +81.9% | 5 qtrs — |
| 30 | BANK OF AMERICA CORP /DE/ | 51.00 +1.0 (+2.0%) | 205.00 +99.0 (+93.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.75 -15.4% | 9 qtrs — |
| 31 | BARCLAYS PLC | — -3.0 (-100.0%) | — -8.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 32 | GROUPE LA FRANCAISE | — -337.0 (-100.0%) | — -603.0 (-100.0%) | 0.00% -0.005 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 33 | CITIGROUP INC | — -1.0 (-100.0%) | — -2.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 34 | ADAR1 CAPITAL MANAGEMENT, LLC | — -12.4K (-100.0%) | — -26.1K (-100.0%) | 0.00% -0.164 pp | 0.00% -0.003 pp | USD— | 3 qtrs SOLD |
| 35 | RANGELEY CAPITAL, LLC | — -10.0K (-100.0%) | — -21.1K (-100.0%) | 0.00% -0.132 pp | 0.00% -0.018 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 35 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Invesco NASDAQ Future Gen 200 ETF QQQS | 0.48% | 105.4K | 0.20% |
| 2 | iShares Micro-Cap ETF IWC | 0.04% | 536.3K | 0.60% |
| 3 | iShares Russell 2000 Growth ETF IWO | 0.01% | 1.04M | 0.24% |
| 4 | Xtrackers Russell 2000 UCITS ETF 1C XRSU.L | 0.01% | 167.8K | 0.30% |
| 5 | Invesco Russell 2000 UCITS ETF RTYS.L | 0.01% | 16.4K | 0.25% |
| 6 | Global X - Russell 2000 ETF RSSL | 0.01% | 75.1K | 0.08% |
| 7 | iShares Russell 2000 BuyWrite ETF IWMW | 0.00% | 2.1K | 0.39% |
| 8 | iShares Russell 2000 ETF IWM | 0.00% | 3.14M | 0.19% |
| 9 | iShares U.S. Small Cap Index ETF (CAD-Hedged) XSU.TO | 0.00% | 20.4K | 0.36% |
| 10 | iShares Russell 2000 Value ETF IWN | 0.00% | 432.8K | 0.24% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
1
Sells
0
Shares acquired
350.8K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+350,800
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-21 | O'Connor James Joseph | Officer | A-Award | A | Employee Stock Option (right to buy) | 350,800 | 6.97 | 2.45M | 350,800 | D | ↗ |
| 2026-03-31 | Kaul Inderjit | Director | A-Award | A | Stock Option (right to buy) | 12,169 | 6.03 | 73.4K | 12,169 | D | ↗ |
| 2025-12-22 | VAN HEEK G JAN | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 3.98 | 199.0K | 50,000 | D | ↗ |
| 2025-12-22 | Race Geoff | Officer | A-Award | A | Employee Stock Option (right to buy) | 1,500,000 | 3.98 | 5.97M | 1,500,000 | D | ↗ |
| 2025-12-22 | Luthringer Remy | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 2,250,000 | 3.98 | 8.96M | 2,250,000 | D | ↗ |
| 2025-12-22 | Laghrissi-Thode Fouzia | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 3.98 | 199.0K | 50,000 | D | ↗ |
| 2025-12-22 | Kupfer David | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 3.98 | 199.0K | 50,000 | D | ↗ |
| 2025-12-22 | Kaul Inderjit | Director | A-Award | A | Stock Option (right to buy) | 364,504 | 3.98 | 1.45M | 364,504 | D | ↗ |
| 2025-12-22 | HASLER HANS PETER | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 3.98 | 199.0K | 50,000 | D | ↗ |
| 2025-12-22 | Ahlholm Frederick W | Officer | A-Award | A | Employee Stock Option (right to buy) | 500,000 | 3.98 | 1.99M | 500,000 | D | ↗ |
| 2025-11-14 | Kaul Inderjit | Director | A-Award | A | Stock Option (right to buy) | 9,500 | 4.11 | 39.0K | 9,500 | D | ↗ |
| 2024-12-05 | VAN HEEK G JAN | Director | A-Award | A | Stock Option (right to buy) | 12,500 | 2.12 | 26.5K | 12,500 | D | ↗ |
| 2024-12-05 | Race Geoff | Officer | A-Award | A | Employee Stock Option (right to buy) | 95,000 | 2.12 | 201.4K | 95,000 | D | ↗ |
| 2024-12-05 | Luthringer Remy | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 105,000 | 2.12 | 222.6K | 105,000 | D | ↗ |
| 2024-12-05 | Laghrissi-Thode Fouzia | Director | A-Award | A | Stock Option (right to buy) | 12,500 | 2.12 | 26.5K | 12,500 | D | ↗ |
| 2024-12-05 | Kupfer David | Director | A-Award | A | Stock Option (right to buy) | 12,500 | 2.12 | 26.5K | 12,500 | D | ↗ |
| 2024-12-05 | HASLER HANS PETER | Director | A-Award | A | Stock Option (right to buy) | 12,500 | 2.12 | 26.5K | 12,500 | D | ↗ |
| 2024-12-05 | Ahlholm Frederick W | Officer | A-Award | A | Employee Stock Option (right to buy) | 47,500 | 2.12 | 100.7K | 47,500 | D | ↗ |
| 2023-10-04 | Race Geoff | Officer | A-Award | A | Employee Stock Option (right to buy) | 87,050 | 6.41 | 558.0K | 87,050 | — | ↗ |
| 2023-10-04 | Luthringer Remy | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 100,450 | 6.41 | 643.9K | 100,450 | — | ↗ |
| 2023-10-04 | Ahlholm Frederick W | Officer | A-Award | A | Employee Stock Option (right to buy) | 42,850 | 6.41 | 274.7K | 42,850 | — | ↗ |
| 2023-09-27 | VAN HEEK G JAN | Director | A-Award | A | Stock Option (right to buy) | 12,500 | 7.30 | 91.3K | 12,500 | — | ↗ |
| 2023-09-27 | Laghrissi-Thode Fouzia | Director | A-Award | A | Stock Option (right to buy) | 12,500 | 7.30 | 91.3K | 12,500 | — | ↗ |
| 2023-09-27 | Kupfer David | Director | A-Award | A | Stock Option (right to buy) | 12,500 | 7.30 | 91.3K | 12,500 | — | ↗ |
| 2023-09-27 | HILLEMAN JERYL L | Director | A-Award | A | Stock Option (right to buy) | 12,500 | 7.30 | 91.3K | 12,500 | — | ↗ |
| 2023-09-27 | HASLER HANS PETER | Director | A-Award | A | Stock Option (right to buy) | 12,500 | 7.30 | 91.3K | 12,500 | — | ↗ |
| 2023-06-27 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 1,275,000 | — | ↗ |
| 2023-05-02 | Luthringer Remy | Director / Officer | S-Sale | D | Common Stock | 3,641 | 3.76 | 13.7K | 68,994 | — | ↗ |
| 2023-05-01 | Race Geoff | Officer | S-Sale | D | Common Stock | 22,082 | 3.85 | 85.0K | 51,324 | — | ↗ |
| 2023-05-01 | Luthringer Remy | Director / Officer | S-Sale | D | Common Stock | 23,753 | 3.85 | 91.4K | 72,635 | — | ↗ |
| 2023-05-01 | Ahlholm Frederick W | Officer | S-Sale | D | Common Stock | 3,580 | 4.48 | 16.0K | 17,518 | — | ↗ |
| 2023-04-28 | Race Geoff | Officer | A-Award | A | Common Stock | 46,987 | 0.00 | — | 73,406 | — | ↗ |
| 2023-04-28 | Luthringer Remy | Director / Officer | A-Award | A | Common Stock | 88,077 | 0.00 | — | 96,388 | — | ↗ |
| 2023-04-28 | Ahlholm Frederick W | Officer | A-Award | A | Common Stock | 19,843 | 0.00 | — | 21,098 | — | ↗ |
| 2022-12-13 | Race Geoff | Officer | A-Award | A | Employee Stock Option (right to buy) | 38,000 | 0.00 | — | 38,000 | — | ↗ |
| 2022-12-13 | Luthringer Remy | Officer | A-Award | A | Employee Stock Option (right to buy) | 45,000 | 0.00 | — | 45,000 | — | ↗ |
| 2022-12-13 | Ahlholm Frederick W | Officer | A-Award | A | Employee Stock Option (right to buy) | 26,000 | 0.00 | — | 26,000 | — | ↗ |
| 2022-08-11 | BARCLAYS PLC | 10% Owner | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-08-08 | BARCLAYS PLC | 10% Owner | — | I | Common Stock, $0.0001 par value per share | 0 | 0.00 | — | 408,430 | — | ↗ |
| 2022-06-10 | VAN HEEK G JAN | Director | A-Award | A | Stock Option (right to buy) | 2,500 | 3.32 | 8.3K | 2,500 | — | ↗ |
| 2022-06-10 | Laghrissi-Thode Fouzia | Director | A-Award | A | Stock Option (right to buy) | 2,500 | 0.00 | — | 2,500 | — | ↗ |
| 2022-06-10 | Kupfer David | Director | A-Award | A | Stock Option (right to buy) | 2,500 | 3.32 | 8.3K | 2,500 | — | ↗ |
| 2022-06-10 | HILLEMAN JERYL L | Director | A-Award | A | Stock Option (right to buy) | 2,500 | 0.00 | — | 2,500 | — | ↗ |
| 2022-06-10 | HASLER HANS PETER | Director | A-Award | A | Stock Option (right to buy) | 2,500 | 0.00 | — | 2,500 | — | ↗ |
| 2022-06-10 | DOYLE WILLIAM F | Director | A-Award | A | Stock Option (right to buy) | 2,500 | 0.00 | — | 2,500 | — | ↗ |
| 2022-02-16 | Race Geoff | Officer | A-Award | A | Employee Stock Option (right to buy) | 200,000 | 0.79 | 158.2K | 200,000 | — | ↗ |
| 2022-02-16 | Luthringer Remy | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 505,000 | 0.79 | 399.5K | 505,000 | — | ↗ |
| 2022-02-16 | Ahlholm Frederick W | Officer | A-Award | A | Employee Stock Option (right to buy) | 180,000 | 0.79 | 142.4K | 180,000 | — | ↗ |
| 2021-12-01 | Kupfer David | Director | S-Sale | D | Common Stock | 55,635 | 0.88 | 49.0K | 163,553 | — | ↗ |
| 2021-06-11 | VAN HEEK G JAN | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 2.90 | 58.0K | 20,000 | — | ↗ |
| 2021-06-11 | Laghrissi-Thode Fouzia | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 2.90 | 58.0K | 20,000 | — | ↗ |
| 2021-06-11 | Kupfer David | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 2.90 | 58.0K | 20,000 | — | ↗ |
| 2021-06-11 | HILLEMAN JERYL L | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 2.90 | 58.0K | 20,000 | — | ↗ |
| 2021-06-11 | HASLER HANS PETER | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 2.90 | 58.0K | 20,000 | — | ↗ |
| 2021-06-11 | DOYLE WILLIAM F | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 2.90 | 116.0K | 40,000 | — | ↗ |
| 2020-12-16 | Reilly Joseph H. | Officer | S-Sale | D | Common Stock | 3,228 | 2.64 | 8.5K | 31,747 | — | ↗ |
| 2020-12-16 | Race Geoff | Officer | S-Sale | D | Common Stock | 6,190 | 2.64 | 16.3K | 211,354 | — | ↗ |
| 2020-12-16 | Luthringer Remy | Director / Officer | S-Sale | D | Common Stock | 1,300 | 2.64 | 3.4K | 66,490 | — | ↗ |
| 2020-12-16 | Ahlholm Frederick W | Officer | S-Sale | D | Common Stock | 1,845 | 2.64 | 4.9K | 10,039 | — | ↗ |
| 2020-12-14 | Reilly Joseph H. | Officer | M-Exempt | D | Restricted Stock Unit | 8,750 | 0.00 | — | 0 | — | ↗ |
| 2020-12-14 | Race Geoff | Officer | M-Exempt | D | Restricted Stock Unit | 12,500 | 0.00 | — | 0 | — | ↗ |
| 2020-12-14 | Luthringer Remy | Director / Officer | M-Exempt | A | Common Stock | 18,750 | 0.00 | — | 67,790 | — | ↗ |
| 2020-12-14 | Ahlholm Frederick W | Officer | M-Exempt | A | Common Stock | 5,000 | 0.00 | — | 11,884 | — | ↗ |
| 2020-10-13 | Smith Devin Whittemore | Officer | A-Award | A | Employee Stock Option (right to buy) | 85,000 | 3.50 | 297.5K | 85,000 | — | ↗ |
| 2020-10-13 | Saoud Jay | Officer | A-Award | A | Employee Stock Option (right to buy) | 100,000 | 3.50 | 350.0K | 100,000 | — | ↗ |
| 2020-10-13 | Reilly Joseph H. | Officer | A-Award | A | Employee Stock Option (right to buy) | 85,000 | 3.50 | 297.5K | 85,000 | — | ↗ |
| 2020-10-13 | Race Geoff | Officer | A-Award | A | Employee Stock Option (right to buy) | 140,000 | 3.50 | 490.0K | 140,000 | — | ↗ |
| 2020-10-13 | Luthringer Remy | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 200,000 | 3.50 | 700.0K | 200,000 | — | ↗ |
| 2020-10-13 | Davidson Michael | Officer | A-Award | A | Employee Stock Option (right to buy) | 85,000 | 3.50 | 297.5K | 85,000 | — | ↗ |
| 2020-10-13 | Ahlholm Frederick W | Officer | A-Award | A | Employee Stock Option (right to buy) | 85,000 | 3.50 | 297.5K | 85,000 | — | ↗ |
| 2020-09-10 | VAN HEEK G JAN | Director | P-Purchase | A | Common Stock | 7,000 | 2.97 | 20.8K | 20,333 | — | ↗ |
| 2020-06-19 | Smith Devin Whittemore | Officer | A-Award | A | Employee Stock Option (right to buy) | 153,531 | 7.11 | 1.09M | 153,531 | — | ↗ |
| 2020-06-19 | Saoud Jay | Officer | A-Award | A | Employee Stock Option (right to buy) | 236,202 | 7.11 | 1.68M | 236,202 | — | ↗ |
| 2020-06-19 | Russell Richard E. | Officer | A-Award | A | Employee Stock Option (right to buy) | 185,025 | 7.11 | 1.32M | 185,025 | — | ↗ |
| 2020-06-19 | Reilly Joseph H. | Officer | A-Award | A | Employee Stock Option (right to buy) | 153,531 | 7.11 | 1.09M | 153,531 | — | ↗ |
| 2020-06-19 | Race Geoff | Officer | A-Award | A | Employee Stock Option (right to buy) | 275,568 | 7.11 | 1.96M | 275,568 | — | ↗ |
| 2020-06-19 | Luthringer Remy | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 354,302 | 7.11 | 2.52M | 354,302 | — | ↗ |
| 2020-06-19 | Davidson Michael | Officer | A-Award | A | Employee Stock Option (right to buy) | 137,784 | 7.11 | 979.6K | 137,784 | — | ↗ |
| 2020-06-19 | Ahlholm Frederick W | Officer | A-Award | A | Employee Stock Option (right to buy) | 137,784 | 7.11 | 979.6K | 137,784 | — | ↗ |
| 2020-06-11 | VAN HEEK G JAN | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 3.40 | 68.0K | 20,000 | — | ↗ |
| 2020-06-11 | Laghrissi-Thode Fouzia | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 3.40 | 68.0K | 20,000 | — | ↗ |
| 2020-06-11 | Kupfer David | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 3.40 | 68.0K | 20,000 | — | ↗ |
| 2020-06-11 | HILLEMAN JERYL L | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 3.40 | 68.0K | 20,000 | — | ↗ |
| 2020-06-11 | HASLER HANS PETER | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 3.40 | 68.0K | 20,000 | — | ↗ |
| 2020-06-11 | DOYLE WILLIAM F | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 3.40 | 136.0K | 40,000 | — | ↗ |
| 2020-05-26 | Ahlholm Frederick W | Officer | S-Sale | D | Common Stock | 8,339 | 15.00 | 125.1K | 6,884 | — | ↗ |
| 2019-12-31 | Smith Devin Whittemore | Officer | A-Award | A | Employee Stock Option (right to buy) | 41,469 | 7.11 | 294.8K | 41,469 | — | ↗ |
| 2019-12-31 | Saoud Jay | Officer | A-Award | A | Employee Stock Option (right to buy) | 63,798 | 7.11 | 453.6K | 63,798 | — | ↗ |
| 2019-12-31 | Russell Richard E. | Officer | A-Award | A | Employee Stock Option (right to buy) | 49,975 | 7.11 | 355.3K | 49,975 | — | ↗ |
| 2019-12-31 | Reilly Joseph H. | Officer | A-Award | A | Employee Stock Option (right to buy) | 41,469 | 7.11 | 294.8K | 41,469 | — | ↗ |
| 2019-12-31 | Race Geoff | Officer | A-Award | A | Employee Stock Option (right to buy) | 74,432 | 7.11 | 529.2K | 74,432 | — | ↗ |
| 2019-12-31 | Luthringer Remy | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 95,698 | 7.11 | 680.4K | 95,698 | — | ↗ |
| 2019-12-31 | Davidson Michael | Officer | A-Award | A | Employee Stock Option (right to buy) | 37,216 | 7.11 | 264.6K | 37,216 | — | ↗ |
| 2019-12-31 | Ahlholm Frederick W | Officer | A-Award | A | Employee Stock Option (right to buy) | 37,216 | 7.11 | 264.6K | 37,216 | — | ↗ |
| 2019-12-17 | Reilly Joseph H. | Officer | S-Sale | D | Common Stock | 2,724 | 7.10 | 19.3K | 26,225 | — | ↗ |
| 2019-12-17 | Race Geoff | Officer | S-Sale | D | Common Stock | 5,826 | 7.10 | 41.4K | 205,044 | — | ↗ |
| 2019-12-17 | Luthringer Remy | Director / Officer | S-Sale | D | Common Stock | 2,412 | 7.10 | 17.1K | 49,040 | — | ↗ |
| 2019-12-17 | Ahlholm Frederick W | Officer | S-Sale | D | Common Stock | 1,557 | 7.10 | 11.1K | 15,223 | — | ↗ |
| 2019-12-14 | Reilly Joseph H. | Officer | M-Exempt | D | Restricted Stock Unit | 8,750 | 0.00 | — | 8,750 | — | ↗ |
| 2019-12-14 | Race Geoff | Officer | M-Exempt | A | Common Stock | 12,500 | 0.00 | — | 210,870 | — | ↗ |
| 2019-12-14 | Luthringer Remy | Director / Officer | M-Exempt | D | Restricted Stock Unit | 18,750 | 0.00 | — | 18,750 | — | ↗ |
| 2019-12-14 | Ahlholm Frederick W | Officer | M-Exempt | D | Restricted Stock Unit | 5,000 | 0.00 | — | 5,000 | — | ↗ |
| 2019-12-12 | Russell Richard E. | Officer | S-Sale | D | Common Stock | 3,113 | 7.42 | 23.1K | 33,770 | — | ↗ |
| 2019-06-27 | DOYLE WILLIAM F | Director | P-Purchase | A | Common Stock | 3,500 | 5.50 | 19.3K | 26,111 | — | ↗ |
| 2019-06-26 | VAN HEEK G JAN | Director | P-Purchase | A | Common Stock | 10,000 | 5.37 | 53.7K | 13,333 | — | ↗ |
| 2019-06-26 | Kupfer David | Director | P-Purchase | A | Common Stock | 10,000 | 5.55 | 55.5K | 219,188 | — | ↗ |
| 2019-06-26 | HILLEMAN JERYL L | Director | P-Purchase | A | Common Stock | 1,000 | 5.25 | 5.3K | 1,000 | — | ↗ |
| 2019-06-26 | HASLER HANS PETER | Director | P-Purchase | A | Common Stock | 10,000 | 5.60 | 56.0K | 10,000 | — | ↗ |
| 2019-06-24 | Index Venture Associates III Ltd | 10% Owner | S-Sale | D | Common Stock | 197,000 | 6.01 | 1.18M | 3,899,189 | — | ↗ |
| 2019-06-20 | Index Venture Associates III Ltd | 10% Owner | S-Sale | D | Common Stock | 33,575 | 4.34 | 145.8K | 4,096,189 | — | ↗ |
| 2019-06-19 | Index Venture Associates III Ltd | 10% Owner | S-Sale | D | Common Stock | 77,243 | 4.44 | 343.2K | 4,129,764 | — | ↗ |
| 2019-06-18 | Index Venture Associates III Ltd | 10% Owner | S-Sale | D | Common Stock | 49,675 | 4.44 | 220.5K | 4,207,007 | — | ↗ |
| 2019-06-17 | Index Venture Associates III Ltd | 10% Owner | S-Sale | D | Common Stock | 56,243 | 4.45 | 250.2K | 4,256,682 | — | ↗ |
| 2019-06-14 | Index Venture Associates III Ltd | 10% Owner | S-Sale | D | Common Stock | 25,169 | 4.50 | 113.2K | 4,312,925 | — | ↗ |
| 2019-06-13 | Index Venture Associates III Ltd | 10% Owner | S-Sale | D | Common Stock | 53,298 | 4.51 | 240.5K | 4,338,094 | — | ↗ |
| 2019-06-12 | Index Venture Associates III Ltd | 10% Owner | S-Sale | D | Common Stock | 26,901 | 4.57 | 123.0K | 4,391,392 | — | ↗ |
| 2019-06-12 | DOYLE WILLIAM F | Director | A-Award | A | Stock option (right to buy) | 20,000 | 4.50 | 90.0K | 20,000 | — | ↗ |
| 2019-06-11 | Index Venture Associates III Ltd | 10% Owner | S-Sale | D | Common Stock | 33,150 | 4.78 | 158.4K | 4,418,293 | — | ↗ |
| 2019-05-31 | VAN HEEK G JAN | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 5.21 | 104.2K | 20,000 | — | ↗ |
| 2019-05-31 | Laghrissi-Thode Fouzia | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 5.21 | 104.2K | 20,000 | — | ↗ |
| 2019-05-31 | Kupfer David | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 5.21 | 104.2K | 20,000 | — | ↗ |
| 2019-05-31 | HILLEMAN JERYL L | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 5.21 | 104.2K | 20,000 | — | ↗ |
| 2019-05-31 | HASLER HANS PETER | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 5.21 | 104.2K | 20,000 | — | ↗ |
| 2019-05-31 | DOYLE WILLIAM F | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 5.21 | 104.2K | 20,000 | — | ↗ |
| 2019-05-20 | Index Venture Associates III Ltd | 10% Owner | S-Sale | D | Common Stock | 200 | 6.08 | 1.2K | 4,451,443 | — | ↗ |
| 2019-05-17 | Index Venture Associates III Ltd | 10% Owner | S-Sale | D | Common Stock | 22,718 | 6.02 | 136.7K | 4,451,643 | — | ↗ |
| 2019-05-16 | Index Venture Associates III Ltd | 10% Owner | S-Sale | D | Common Stock | 44,836 | 6.37 | 285.7K | 4,474,361 | — | ↗ |
| 2019-05-15 | Index Venture Associates III Ltd | 10% Owner | S-Sale | D | Common Stock | 53,418 | 6.64 | 354.5K | 4,519,197 | — | ↗ |
| 2019-05-14 | Index Venture Associates III Ltd | 10% Owner | S-Sale | D | Common Stock | 36,574 | 7.05 | 258.0K | 4,572,615 | — | ↗ |
| 2018-12-20 | DOYLE WILLIAM F | Director | P-Purchase | A | Common Stock | 2,000 | 6.50 | 13.0K | 22,611 | — | ↗ |
| 2018-12-17 | Reilly Joseph H. | Officer | S-Sale | D | Common Stock | 2,728 | 7.46 | 20.4K | 20,199 | — | ↗ |
| 2018-12-17 | Race Geoff | Officer | S-Sale | D | Common Stock | 5,999 | 7.46 | 44.8K | 198,370 | — | ↗ |
| 2018-12-17 | Luthringer Remy | Director / Officer | S-Sale | D | Common Stock | 2,604 | 7.46 | 19.4K | 32,702 | — | ↗ |
| 2018-12-17 | Ahlholm Frederick W | Officer | S-Sale | D | Common Stock | 1,559 | 7.46 | 11.6K | 11,780 | — | ↗ |
| 2018-12-14 | Reilly Joseph H. | Officer | M-Exempt | A | Common Stock | 8,750 | 0.00 | — | 22,927 | — | ↗ |
| 2018-12-14 | Race Geoff | Officer | M-Exempt | D | Restricted Stock Unit | 12,500 | 0.00 | — | 25,000 | — | ↗ |
| 2018-12-14 | Luthringer Remy | Director / Officer | M-Exempt | A | Common Stock | 18,750 | 0.00 | — | 35,306 | — | ↗ |
| 2018-12-14 | Ahlholm Frederick W | Officer | M-Exempt | D | Restricted Stock Unit | 5,000 | 0.00 | — | 10,000 | — | ↗ |
| 2018-12-12 | Russell Richard E. | Officer | S-Sale | D | Common Stock | 3,117 | 7.96 | 24.8K | 36,883 | — | ↗ |
| 2018-12-11 | Smith Devin Whittemore | Officer | A-Award | A | Employee Stock Option (right to buy) | 120,000 | 7.96 | 955.2K | 120,000 | — | ↗ |
| 2018-12-11 | Saoud Jay | Officer | A-Award | A | Employee Stock Option (right to buy) | 96,000 | 7.96 | 764.2K | 96,000 | — | ↗ |
| 2018-12-11 | Russell Richard E. | Officer | A-Award | A | Employee Stock Option (right to buy) | 260,000 | 7.96 | 2.07M | 260,000 | — | ↗ |
| 2018-12-11 | Reilly Joseph H. | Officer | A-Award | A | Employee Stock Option (right to buy) | 120,000 | 7.96 | 955.2K | 120,000 | — | ↗ |
| 2018-12-11 | Race Geoff | Officer | A-Award | A | Employee Stock Option (right to buy) | 175,000 | 7.96 | 1.39M | 175,000 | — | ↗ |
| 2018-12-11 | Luthringer Remy | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 410,000 | 7.96 | 3.26M | 410,000 | — | ↗ |
| 2018-12-11 | Davidson Michael | Officer | A-Award | A | Employee Stock Option (right to buy) | 175,000 | 7.96 | 1.39M | 175,000 | — | ↗ |
| 2018-12-11 | DOYLE WILLIAM F | Director | P-Purchase | A | Common Stock | 4,000 | 7.95 | 31.8K | 20,611 | — | ↗ |
| 2018-12-11 | Ahlholm Frederick W | Officer | A-Award | A | Employee Stock Option (right to buy) | 120,000 | 7.96 | 955.2K | 120,000 | — | ↗ |
| 2018-12-10 | DOYLE WILLIAM F | Director | P-Purchase | A | Common Stock | 2,000 | 8.00 | 16.0K | 16,611 | — | ↗ |
| 2018-11-20 | DOYLE WILLIAM F | Director | P-Purchase | A | Common Stock | 2,000 | 8.20 | 16.4K | 14,611 | — | ↗ |
| 2018-10-11 | DOYLE WILLIAM F | Director | P-Purchase | A | Common Stock | 600 | 10.00 | 6.0K | 12,611 | — | ↗ |
| 2018-10-01 | Reilly Joseph H. | Officer | M-Exempt | D | Employee Stock Option (Right to Buy) | 15,000 | 4.71 | 70.7K | 27,400 | — | ↗ |
| 2018-10-01 | Index Venture Associates III Ltd | 10% Owner | S-Sale | D | Common Stock | 15,444 | 12.35 | 190.7K | 4,609,189 | — | ↗ |
| 2018-09-28 | Index Venture Associates III Ltd | 10% Owner | S-Sale | D | Common Stock | 34,589 | 12.62 | 436.3K | 4,624,633 | — | ↗ |
| 2018-09-27 | Index Venture Associates III Ltd | 10% Owner | S-Sale | D | Common Stock | 31,684 | 12.57 | 398.3K | 4,659,222 | — | ↗ |
| 2018-09-17 | DOYLE WILLIAM F | Director | P-Purchase | A | Common Stock | 1,800 | 10.50 | 18.9K | 12,011 | — | ↗ |
| 2018-09-14 | DOYLE WILLIAM F | Director | P-Purchase | A | Common Stock | 200 | 10.50 | 2.1K | 10,211 | — | ↗ |
| 2018-09-13 | DOYLE WILLIAM F | Director | P-Purchase | A | Common Stock | 2,000 | 10.50 | 21.0K | 10,011 | — | ↗ |
| 2018-09-11 | DOYLE WILLIAM F | Director | P-Purchase | A | Common Stock | 4,011 | 9.72 | 39.0K | 8,011 | — | ↗ |
| 2018-09-10 | DOYLE WILLIAM F | Director | P-Purchase | A | Common Stock | 4,000 | 9.88 | 39.5K | 4,000 | — | ↗ |
| 2018-08-23 | Reilly Joseph H. | Officer | M-Exempt | A | Common Stock | 25,000 | 4.71 | 117.8K | 39,177 | — | ↗ |
| 2018-08-01 | Smith Devin Whittemore | Officer | A-Award | A | Employee Stock Option (Righ to Buy) | 200,000 | 7.95 | 1.59M | 200,000 | — | ↗ |
| 2018-08-01 | DOYLE WILLIAM F | Director | A-Award | A | Stock Option (Right to Buy) | 20,000 | 7.95 | 159.0K | 20,000 | — | ↗ |
| 2018-07-23 | Smith Devin Whittemore | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-07-16 | HILLEMAN JERYL L | Director | A-Award | A | Stock Option (Right to Buy) | 40,000 | 8.20 | 328.0K | 40,000 | — | ↗ |
| 2018-06-07 | VAN HEEK G JAN | Director | A-Award | A | Stock Option (Right to Buy) | 20,000 | 8.25 | 165.0K | 20,000 | — | ↗ |
| 2018-06-07 | Laghrissi-Thode Fouzia | Director | A-Award | A | Stock Option (Right to Buy) | 20,000 | 8.25 | 165.0K | 20,000 | — | ↗ |
| 2018-06-07 | Kupfer David | Director | A-Award | A | Stock Option (Right to Buy) | 20,000 | 8.25 | 165.0K | 20,000 | — | ↗ |
| 2018-06-07 | HASLER HANS PETER | Director | A-Award | A | Stock Option (Right to Buy) | 20,000 | 8.25 | 165.0K | 20,000 | — | ↗ |
| 2018-06-07 | DOYLE WILLIAM F | Director | A-Award | A | Stock Option (Right to Buy) | 20,000 | 8.25 | 165.0K | 20,000 | — | ↗ |
| 2018-01-31 | Beer Marc D | Director | A-Award | A | Stock Option (Right to Buy) | 12,500 | 10.00 | 125.0K | 12,500 | — | ↗ |
| 2018-01-02 | Luthringer Remy | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 200,000 | 6.20 | 1.24M | 200,000 | — | ↗ |
| 2017-12-14 | Reilly Joseph H. | Officer | M-Exempt | A | Common Stock | 8,750 | 0.00 | — | 17,083 | — | ↗ |
| 2017-12-14 | Race Geoff | Officer | S-Sale | D | Common Stock | 5,829 | 5.79 | 33.7K | 191,869 | — | ↗ |
| 2017-12-14 | Luthringer Remy | Director / Officer | M-Exempt | A | Common Stock | 18,750 | 0.00 | — | 18,750 | — | ↗ |
| 2017-12-14 | Ahlholm Frederick W | Officer | M-Exempt | A | Common Stock | 5,000 | 0.00 | — | 10,000 | — | ↗ |
| 2017-12-13 | Saoud Jay | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 175,000 | 6.10 | 1.07M | 175,000 | — | ↗ |
| 2017-12-13 | Reilly Joseph H. | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 120,000 | 6.10 | 732.0K | 120,000 | — | ↗ |
| 2017-12-13 | Race Geoff | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 200,000 | 6.10 | 1.22M | 200,000 | — | ↗ |
| 2017-12-13 | Luthringer Remy | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 350,000 | 6.10 | 2.14M | 350,000 | — | ↗ |
| 2017-12-13 | Davidson Michael | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 125,000 | 6.10 | 762.5K | 125,000 | — | ↗ |
| 2017-12-13 | Ahlholm Frederick W | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 120,000 | 6.10 | 732.0K | 120,000 | — | ↗ |
| 2017-12-11 | Russell Richard E. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-12-10 | HASLER HANS PETER | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-12-10 | DOYLE WILLIAM F | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-09-01 | Saoud Jay | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 100,000 | 6.45 | 645.0K | 100,000 | — | ↗ |
| 2017-08-31 | Saoud Jay | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-08-29 | JOHNSON & JOHNSON | 10% Owner | J-Other | D | Common Stock | 3,892,256 | 0.00 | 389.23 | 0 | — | ↗ |
| 2017-07-24 | Vandervelpen Nico | Director | D-Return | D | Stock Option (Right to Buy) | 12,500 | 10.20 | 127.5K | 0 | — | ↗ |
| 2017-06-01 | Vandervelpen Nico | Director | A-Award | A | Stock Option (Right to Buy) | 12,500 | 10.00 | 125.0K | 12,500 | — | ↗ |
| 2017-06-01 | VAN HEEK G JAN | Director | A-Award | A | Stock Option (Right to Buy) | 12,500 | 10.00 | 125.0K | 12,500 | — | ↗ |
| 2017-06-01 | Levine Mark S. | Officer | M-Exempt | D | Employee Stock Option (Right to Buy) | 17,500 | 5.19 | 90.8K | 39,774 | — | ↗ |
| 2017-06-01 | Laghrissi-Thode Fouzia | Director | A-Award | A | Stock Option (Right to Buy) | 12,500 | 10.00 | 125.0K | 12,500 | — | ↗ |
| 2017-06-01 | Kupfer David | Director | A-Award | A | Stock Option (Right to Buy) | 12,500 | 10.00 | 125.0K | 12,500 | — | ↗ |
| 2017-06-01 | Beer Marc D | Director | A-Award | A | Stock Option (Right to Buy) | 12,500 | 10.00 | 125.0K | 12,500 | — | ↗ |
| 2017-06-01 | Ahlholm Frederick W | Officer | M-Exempt | A | Common Stock | 14,381 | 5.19 | 74.6K | 19,381 | — | ↗ |
| 2017-03-20 | Beer Marc D | Director | P-Purchase | A | Common Stock | 25,000 | 7.89 | 197.3K | 50,000 | — | ↗ |
| 2017-03-17 | Beer Marc D | Director | P-Purchase | A | Common Stock | 25,000 | 8.34 | 208.5K | 25,000 | — | ↗ |
| 2017-02-06 | Race Geoff | Officer | S-Sale | D | Common Stock | 1,692 | 11.00 | 18.6K | 185,198 | — | ↗ |
| 2017-02-06 | Luthringer Remy | Director / Officer | M-Exempt | A | Common Stock | 2,185 | 4.71 | 10.3K | 2,185 | — | ↗ |
Executive team
Top executives
Shares Outstanding
6.99M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Dr. Remy Luthringer Chief Executive Officer | 675.0K | 482.6K | — | 8.19M | — | 6.5K | 9.35M | 87.55% | ↗ |
| 2 | 2025 | Geoffrey Race Former President | 511.7K | 307.0K | — | 5.46M | — | 3.3K | 6.28M | 86.91% | ↗ |
| 3 | 2025 | Frederick Ahlholm Chief Financial Officer | 467.5K | 168.3K | — | 1.82M | — | 13.4K | 2.47M | 73.71% | ↗ |
| 4 | 2024 | Dr. Remy Luthringer Chief Executive Officer | 649.1K | 357.0K | — | 197.4K | — | 6.5K | 1.21M | 16.31% | ↗ |
| 5 | 2024 | Dr. Remy Luthringer Chief Executive Officer | 649.1K | 357.0K | — | 197.4K | — | 6.5K | 1.21M | 16.31% | ↗ |
| 6 | 2024 | Geoffrey Race President | 492.0K | 246.0K | — | 178.6K | — | 3.1K | 919.7K | 19.42% | ↗ |
| 7 | 2024 | Geoffrey Race Former President | 492.0K | 246.0K | — | 178.6K | — | 3.1K | 919.7K | 19.42% | ↗ |
| 8 | 2024 | Frederick Ahlholm Chief Financial Officer | 449.5K | 202.3K | — | 89.3K | — | 13.1K | 754.2K | 11.84% | ↗ |
| 9 | 2024 | Frederick Ahlholm Chief Financial Officer | 449.5K | 202.3K | — | 89.3K | — | 13.1K | 754.2K | 11.84% | ↗ |
| 10 | 2023 | Dr. Remy Luthringer Chief Executive Officer | 624.1K | 644.4K | — | 560.5K | — | 6.1K | 1.84M | 30.54% | ↗ |
| 11 | 2023 | Geoffrey Race President | 473.1K | 437.1K | — | 485.7K | — | 3.1K | 1.40M | 34.72% | ↗ |
| 12 | 2023 | Frederick Ahlholm SVP, Chief Financial Officer and Secretary | 432.2K | 281.3K | — | 239.1K | — | 12.5K | 965.1K | 24.77% | ↗ |
| 13 | 2023 | Frederick Ahlholm Chief Financial Officer | 432.2K | 281.3K | — | 239.1K | — | 12.5K | 965.1K | 24.77% | ↗ |
| 14 | 2022 | Dr. Remy Luthringer Chief Executive Officer | 600.1K | 247.5K | — | 421.1K | — | 5.9K | 1.27M | 33.04% | ↗ |
| 15 | 2022 | Geoffrey Race President | 454.9K | 170.6K | — | 214.3K | — | 3.0K | 842.8K | 25.43% | ↗ |
| 16 | 2022 | Frederick Ahlholm SVP, Chief Financial Officer and Secretary | 415.6K | 140.3K | — | 173.6K | — | 11.6K | 741.0K | 23.42% | ↗ |
| 17 | 2021 | Dr. Remy Luthringer Chief Executive Officer | 584.9K | 604.2K | — | — | — | — | 1.19M | 0.00% | ↗ |
| 18 | 2021 | Geoffrey Race President | 442.3K | 434.8K | — | — | — | 3.3K | 880.4K | 0.00% | ↗ |
| 19 | 2021 | Michael Davidson Chief Medical Officer | 399.7K | 257.8K | — | — | — | — | 657.5K | 0.00% | ↗ |
| 20 | 2021 | Frederick Ahlholm SVP, Chief Financial Officer and Secretary | 379.7K | 220.0K | — | — | — | 11.0K | 610.7K | 0.00% | ↗ |
| 21 | 2020 | Dr. Remy Luthringer Chief Executive Officer | 565.1K | 282.6K | — | 995.8K | — | 2.6K | 1.85M | 53.94% | ↗ |
| 22 | 2020 | Geoffrey Race Executive Vice President, Chief Financial Officer and Chief Business Officer | 427.3K | 213.7K | — | 740.6K | — | 3.2K | 1.38M | 53.48% | ↗ |
| 23 | 2020 | Geoffrey Race President | 427.3K | 213.7K | — | 740.6K | — | 3.2K | 1.38M | 53.48% | ↗ |
| 24 | 2020 | Jay Saoud Senior Vice President, Head of Research and Development | 376.0K | 225.6K | — | 591.2K | — | 12.2K | 1.21M | 49.06% | ↗ |
| 25 | 2019 | Dr. Remy Luthringer Chief Executive Officer | 543.4K | 190.2K | — | 428.9K | — | 2.5K | 1.16M | 36.82% | ↗ |
| 26 | 2019 | Geoffrey Race Executive Vice President, Chief Financial Officer and Chief Business Officer | 410.9K | 102.7K | — | 333.6K | — | 3.2K | 850.4K | 39.23% | ↗ |
| 27 | 2019 | Richard Russell President | 491.6K | 103.2K | — | 224.0K | — | 14.9K | 833.7K | 26.86% | ↗ |
| 28 | 2019 | Jay Saoud Senior Vice President, Head of Research and Development | 351.5K | 110.4K | — | 285.9K | — | 11.5K | 759.3K | 37.66% | ↗ |
| 29 | 2018 | Dr. Remy Luthringer Chief Executive Officer | 525.0K | 196.9K | — | 3.19M | — | 2.5K | 3.91M | 81.48% | ↗ |
| 30 | 2018 | Richard Russell President | 475.0K | 278.1K | — | 1.45M | — | 15.0K | 2.22M | 65.42% | ↗ |
| 31 | 2018 | Devin Smith Senior Vice President and General Counsel | 154.3K | 96.3K | — | 1.79M | — | 4.8K | 2.04M | 87.50% | ↗ |
| 32 | 2018 | Geoffrey Race Executive Vice President, Chief Financial Officer and Chief Business Officer | 397.0K | 148.9K | — | 978.3K | — | 3.3K | 1.53M | 64.04% | ↗ |
| 33 | 2017 | Richard Russell President | 28.9K | — | 242.0K | 3.42M | — | — | 3.69M | 99.22% | ↗ |
| 34 | 2017 | Michael Davidson Chief Medical Officer | 333.1K | 218.8K | — | 2.29M | — | — | 2.84M | 80.59% | ↗ |
| 35 | 2017 | Dr. Remy Luthringer President and Chief Executive Officer | 445.4K | 278.4K | — | 1.55M | — | 2.6K | 2.28M | 68.15% | ↗ |
| 36 | 2017 | Dr. Remy Luthringer Chief Executive Officer | 445.4K | 278.4K | — | 1.55M | — | 2.6K | 2.28M | 68.15% | ↗ |
| 37 | 2017 | Geoffrey Race Executive Vice President, Chief Financial Officer and Chief Business Officer | 384.3K | 240.2K | — | 888.0K | — | 3.2K | 1.52M | 58.58% | ↗ |
| 38 | 2016 | Dr. Remy Luthringer President and Chief Executive Officer | 387.3K | 290.5K | 1.01M | 1.40M | — | 2.4K | 3.09M | 77.98% | ↗ |
| 39 | 2016 | Geoffrey Race Executive Vice President, Chief Financial Officer and Chief Business Officer | 334.2K | 250.6K | 672.5K | 933.0K | — | 3.3K | 2.19M | 73.19% | ↗ |
| 40 | 2016 | Joseph Reilly Senior Vice President and Chief Operating Officer | 281.1K | 168.7K | 470.8K | 559.8K | — | 11.2K | 1.49M | 69.09% | ↗ |
| 41 | 2016 | Michael Davidson Chief Medical Officer | 255.0K | — | — | 333.1K | — | — | 588.1K | 56.64% | ↗ |
| 42 | 2015 | Remy Luthringer, Ph.D. President and Chief Executive Officer | 376.0K | 416.2K | — | 2.73M | — | — | 3.52M | 77.49% | ↗ |
| 43 | 2015 | Dr. Remy Luthringer President and Chief Executive Officer | 376.0K | 416.2K | — | 2.73M | — | — | 3.52M | 77.49% | ↗ |
| 44 | 2015 | Geoffrey Race Executive Vice President, Chief Financial Officer and Chief Business Officer | 324.5K | 308.2K | — | 1.47M | — | 4.0K | 2.11M | 69.76% | ↗ |
| 45 | 2015 | Joseph Reilly Senior Vice President and Chief Operating Officer | 273.0K | 101.9K | — | 466.9K | — | 10.8K | 852.5K | 54.77% | ↗ |
| 46 | 2015 | Frederick Ahlholm, CPA Senior Vice President and Chief Accounting Officer | 273.0K | 104.8K | — | 466.9K | — | 689.00 | 845.4K | 55.23% | ↗ |
| 47 | 2014 | Remy Luthringer, Ph.D. President and Chief Executive Officer | 213.8K | 144.0K | 10.54M | 3.32M | — | 56.4K | 14.28M | 97.10% | ↗ |
| 48 | 2014 | Remy Luthringer, PhD President and Chief Executive Officer | 213.8K | 50.0K | 10.54M | 3.32M | — | 56.4K | 14.18M | 97.74% | ↗ |
| 49 | 2014 | Rogerio Vivaldi, MD Chief Executive Officer | 391.8K | 250.0K | — | 2.55M | — | 642.7K | 3.83M | 66.48% | ↗ |
| 50 | 2014 | Geoffrey Race Executive Vice President, Chief Financial Officer and Chief Business Officer | 210.0K | 253.8K | — | 1.77M | — | 114.0K | 2.35M | 75.40% | ↗ |
| 51 | 2014 | Geoff Race Executive Vice President and Chief Financial Officer | 210.0K | 175.0K | — | 1.77M | — | 114.0K | 2.27M | 78.02% | ↗ |
| 52 | 2014 | Frederick Ahlholm, CPA Senior Vice President and Chief Accounting Officer | 154.6K | 109.6K | — | 477.8K | — | 77.0K | 819.0K | 58.34% | ↗ |
| 53 | 2014 | Frederick Ahlholm, CPA Vice President and Chief Accounting Officer | 154.6K | 75.0K | — | 477.8K | — | 77.0K | 784.3K | 60.91% | ↗ |
| 54 | 2013 | Rogerio Vivaldi, MD Chief Executive Officer | 70.8K | — | — | 4.22M | — | — | 4.29M | 98.35% | ↗ |
| 55 | 2013 | Geoff Race Executive Vice President and Chief Financial Officer | — | — | 232.6K | — | — | 171.0K | 403.6K | 57.64% | ↗ |
| 56 | 2013 | Remy Luthringer, PhD President and Chief Executive Officer | — | — | — | — | — | 169.2K | 169.2K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Remy Luthringer | Executive Chairman & Chief Executive Officer | 1M | — |
| Geoffrey Robin Race | President | 741.1K | male |
| Michael Davidson | Chief Medical Officer | 657.5K | — |
| Frederick W. Ahlholm | Senior Vice President, Chief Financial Officer & Secretary | 649.2K | male |
| Joseph Reilly | Senior Vice President & Chief Operating Officer | 461.0K | male |
| James O'Connor | Chief Business Officer & General Counsel | — | male |
| William Boni | Vice President of Investor Relations & Corporation Communications | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NERV
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
